您当前的位置：
首页 >
文章列表页 >
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
更新时间：2026-07-16

    • Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 16, Pages: 275-284(2026)

    • DOI：10.13422/j.cnki.syfjx.20252292    

      CLC： R242;R543;R856.2

    • Received：28 March 2025，

      Revised：2025-07-01，

      Accepted：24 July 2025，

      Online First：25 July 2025，

      Published：20 August 2026

    移动端阅览

  • LU Zhen,OU Xinyan,ZHOU Muhan,et al.Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(16):275-284. DOI： 10.13422/j.cnki.syfjx.20252292.

  •  
  •  

0

Views

6

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Effect and Molecular Mechanisms of Danlou Tablet on Hepatic Lipid Deposition in ApoE-/- Atherosclerotic Mice Through Regulation of SIRT6/CREB/Nor1 Signaling Pathway-mediated Autophagy
Mechanism of Danlou Tablets in Ameliorating Hepatic Lipid Deposition by Regulating circCRIM1/miR-342-3p/SOX6-mediated Fatty Acid Synthesis
Pathogenesis Evolution of Atherosclerosis Induced by Novel Turbid-toxin Microplastics from Perspective of "Body Fluids and Blood Stasis Mixing"
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway

Related Author

LI Yunlun
XIANG Jiao
LUO Jieying
LIAO Daiyuan
LI Fulai
YI Rui
LIANG Yong
MO Zunhui

Related Institution

School of Chinese Materia Medica，Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory， Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.
Liaoning University of Traditional Chinese Medicine（TCM）
Affiliated Hospital of Liaoning University of TCM
0